Surgical Outcomes and Prognostic Factors of G3 Pancreatic Neuroendocrine Carcinomas: A Consecutive Analysis Based on Previous Study Results

In 2017, the World Health Organization (WHO) officially defined pancreatic neuroendocrine neoplasms into well-differentiated tumors, namely G1/G2/G3 pancreatic neuroendocrine tumors, and poorly differentiated carcinomas referring to G3 pancreatic neuroendocrine carcinomas (p-NECs). However, the surg...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xinmei, Yang, Min, Tian, Bole, Liu, Xubao, Duan, Kaiti, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181221/
https://www.ncbi.nlm.nih.gov/pubmed/35683561
http://dx.doi.org/10.3390/jcm11113176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181221/
https://www.ncbi.nlm.nih.gov/pubmed/35683561
http://dx.doi.org/10.3390/jcm11113176

Ejemplares similares